

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb312</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Effects of Hypoxia on Biology of Human Leukemia T-cell Line (MOLT-4 cells) Co-cultured with Bone Marrow Mesenchymal Stem Cells</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Baharaghdam</surname><given-names>Sina</given-names></name></contrib><aff>Genetic Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Yousefi</surname><given-names>Mehdi</given-names></name></contrib><aff>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Movasaghpour</surname><given-names>Ali Akbar</given-names></name></contrib><aff>Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Solali</surname><given-names>Saeed</given-names></name></contrib><aff>Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Talebi</surname><given-names>Mehdi</given-names></name></contrib><aff>Department of Medical Physics, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</aff><aff>Nanobiology and Nanomedicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</aff><aff>Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ahani-Nahayati</surname><given-names>Milad</given-names></name></contrib><aff>Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Lotfimehr</surname><given-names>Hamid</given-names></name></contrib><aff>Nanobiology and Nanomedicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Shamsasanjan</surname><given-names>Karim</given-names></name></contrib><aff>Department of Theriogenology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran</aff><aff>Theriogenology Association, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>10</volume>
      <issue>2</issue>
      <fpage>62</fpage>
      <lpage>68</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>2</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>5</month>
          <year>2017</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: One of the most significant problems in the treatment of leukemia is the expansion of resistance to chemotherapeutic agents. Therefore, assessing the drug resistance and especially the drug resistance genes of leukemic cells is important in any treatment. The impact of Mesenchymal Stem Cells (MSCs) and hypoxic condition have been observed in the biological performance of majority of leukemic cells.&lt;br /&gt;
Methods: MOLT-4 cells were co-cultured with MSCs in the hypoxic condition induced by Cobalt Chloride (CoCl&lt;sub&gt;2&lt;/sub&gt;) for 6 and 24 &lt;em&gt;hr&lt;/em&gt;. Then, apoptosis of cells was analyzed using annexin-V/PI staining and expression of the drug resistance genes including MDR1, MRP, and BCRP along with apoptotic and anti-apoptotic genes, including BAX and BCL2, was evaluated by real-time PCR.&lt;br /&gt;
Results: The hypoxic condition for MOLT-4 cells co-cultured with MSCs could significantly increase the expression of MDR1 and BCRP genes (p&amp;lt;0.05) which are involved in drug resistance. Also, the results indicated that this condition significantly increases the expression of BCL2 (p&amp;lt;0.05) and reduces the apoptosis in MOLT- 4 cells co-cultured with MSCs in the hypoxic condition.&lt;br /&gt;
Conclusions: These effects can demonstrate the important role of hypoxia and MSCs on the biological behavior of Acute Lymphoblastic Leukemia (ALL) cells that may lead to particular treatment outcomes.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
